SOD2 and Hermansky-Pudlak syndrome: Moreover, HPS treatment significantly reduced hepatic reactive oxygen species (ROS) levels and dihydroethidium (DHE)-positive staining and up-regulated superoxide dismutase 2 (SOD2) and catalase (CAT) mRNA expressions (Figure 3E-3G).